NEW YORK (GenomeWeb News) – Decode Genetics reported after the close of the market on Tuesday that its fourth-quarter 2008 revenues increased 21 percent and its net loss dropped sharply. But the firm only has enough liquid assets to fund operations into the second quarter of this year, and said that it is seeking additional funds through a variety of options.

The Reykjavik, Iceland-based genetic test and drug developer brought in revenues of $16.1 million for the three-month period ended Dec. 31, 2008, compared to revenues of $13.3 million for the fourth quarter of 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.